Loading…

The natural elimination rate of procalcitonin in patients with normal and impaired renal function

Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half...

Full description

Saved in:
Bibliographic Details
Published in:Intensive care medicine 2000-03, Vol.26 (S2), p.S212-S216
Main Authors: Meisner, M., Schmidt, J., Hüttner, H., Tschaikowsky, K.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3
cites
container_end_page S216
container_issue S2
container_start_page S212
container_title Intensive care medicine
container_volume 26
creator Meisner, M.
Schmidt, J.
Hüttner, H.
Tschaikowsky, K.
description Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half-life time of PCT after peak concentrations in patients with normal and impaired renal function. We also have analyzed the influence of patients age and gender on PCT elimination kinetic.¶Design: Prospective clinical study. Renal dysfunction was assessed by plasma creatinine. The half-life time of PCT was evaluated 24 and 48 h after acute induction of PCT, when the focus of PCT induction has rapidly been eliminated.¶Setting: Intensive care unit of our University hospital, a tertiary health care institution.¶Patients: 69 patients were included into the study.¶Interventions: None.¶Measurements and results: The half-life-time of PCT was not significantly altered during renal dysfunction (26.1-33.1 h, 25-50 percentiles, creatinine clearance < 30 ml/min) when compared with normal renal function (22.3-28.9 h). It neither correlated with creatinine clearance (p = 0.14), nor age (p = 0.99) or gender (p = 0.90, Pearson product-moment correlation).¶Conclusions: The data of the present study demonstrate that assement of PCT kinetic can also be used for diagnostic and prognostic reasons in patients with renal dysfunction. It may, however, exceed 24 h also in patients with normal renal function. As to the present knowledge, renal secretion does not contribute as a main pathway to PCT elimination.[PUBLICATION ABSTRACT]
doi_str_mv 10.1007/s001340051146
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_992880200</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2629295361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3</originalsourceid><addsrcrecordid>eNpVkM1LxDAQxYMouK4evQfv1clXmz3K4hcseFnPJUkTNkub1CRF_O_NohdhYJiZNz8eD6FbAvcEoHvIAIRxAEEIb8_QinBGG0KZPEcrYJw2vOX0El3lfKzKrhVkhdT-YHFQZUlqxHb0k6-DjwEnVSyODs8pGjUaX2LwAdea692GkvGXLwccYprqpwoD9tOsfLIDTjbUlVuCOZGu0YVTY7Y3f32NPp6f9tvXZvf-8rZ93DWGbHhpnLDCUMOkBKnBSXB2EK3hRFtGneK6I602TmrNJQfaESNa3ZJBaMWt45at0d0vtzr-XGwu_TEuqTrJ_WZDK5YCVFHzKzIp5pys6-fkJ5W-ewL9KcT-X4jsB5VjZcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>992880200</pqid></control><display><type>article</type><title>The natural elimination rate of procalcitonin in patients with normal and impaired renal function</title><source>Springer Nature</source><creator>Meisner, M. ; Schmidt, J. ; Hüttner, H. ; Tschaikowsky, K.</creator><creatorcontrib>Meisner, M. ; Schmidt, J. ; Hüttner, H. ; Tschaikowsky, K.</creatorcontrib><description>Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half-life time of PCT after peak concentrations in patients with normal and impaired renal function. We also have analyzed the influence of patients age and gender on PCT elimination kinetic.¶Design: Prospective clinical study. Renal dysfunction was assessed by plasma creatinine. The half-life time of PCT was evaluated 24 and 48 h after acute induction of PCT, when the focus of PCT induction has rapidly been eliminated.¶Setting: Intensive care unit of our University hospital, a tertiary health care institution.¶Patients: 69 patients were included into the study.¶Interventions: None.¶Measurements and results: The half-life-time of PCT was not significantly altered during renal dysfunction (26.1-33.1 h, 25-50 percentiles, creatinine clearance &lt; 30 ml/min) when compared with normal renal function (22.3-28.9 h). It neither correlated with creatinine clearance (p = 0.14), nor age (p = 0.99) or gender (p = 0.90, Pearson product-moment correlation).¶Conclusions: The data of the present study demonstrate that assement of PCT kinetic can also be used for diagnostic and prognostic reasons in patients with renal dysfunction. It may, however, exceed 24 h also in patients with normal renal function. As to the present knowledge, renal secretion does not contribute as a main pathway to PCT elimination.[PUBLICATION ABSTRACT]</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s001340051146</identifier><language>eng</language><publisher>Heidelberg: Springer Nature B.V</publisher><subject>Creatinine ; Dopamine ; Gender ; Inflammation ; Intensive care ; Molecular weight ; Patients ; Plasma ; Proteins ; Renal replacement therapy ; Sepsis ; Urine</subject><ispartof>Intensive care medicine, 2000-03, Vol.26 (S2), p.S212-S216</ispartof><rights>Springer-Verlag Berlin Heidelberg 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Meisner, M.</creatorcontrib><creatorcontrib>Schmidt, J.</creatorcontrib><creatorcontrib>Hüttner, H.</creatorcontrib><creatorcontrib>Tschaikowsky, K.</creatorcontrib><title>The natural elimination rate of procalcitonin in patients with normal and impaired renal function</title><title>Intensive care medicine</title><description>Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half-life time of PCT after peak concentrations in patients with normal and impaired renal function. We also have analyzed the influence of patients age and gender on PCT elimination kinetic.¶Design: Prospective clinical study. Renal dysfunction was assessed by plasma creatinine. The half-life time of PCT was evaluated 24 and 48 h after acute induction of PCT, when the focus of PCT induction has rapidly been eliminated.¶Setting: Intensive care unit of our University hospital, a tertiary health care institution.¶Patients: 69 patients were included into the study.¶Interventions: None.¶Measurements and results: The half-life-time of PCT was not significantly altered during renal dysfunction (26.1-33.1 h, 25-50 percentiles, creatinine clearance &lt; 30 ml/min) when compared with normal renal function (22.3-28.9 h). It neither correlated with creatinine clearance (p = 0.14), nor age (p = 0.99) or gender (p = 0.90, Pearson product-moment correlation).¶Conclusions: The data of the present study demonstrate that assement of PCT kinetic can also be used for diagnostic and prognostic reasons in patients with renal dysfunction. It may, however, exceed 24 h also in patients with normal renal function. As to the present knowledge, renal secretion does not contribute as a main pathway to PCT elimination.[PUBLICATION ABSTRACT]</description><subject>Creatinine</subject><subject>Dopamine</subject><subject>Gender</subject><subject>Inflammation</subject><subject>Intensive care</subject><subject>Molecular weight</subject><subject>Patients</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Renal replacement therapy</subject><subject>Sepsis</subject><subject>Urine</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LxDAQxYMouK4evQfv1clXmz3K4hcseFnPJUkTNkub1CRF_O_NohdhYJiZNz8eD6FbAvcEoHvIAIRxAEEIb8_QinBGG0KZPEcrYJw2vOX0El3lfKzKrhVkhdT-YHFQZUlqxHb0k6-DjwEnVSyODs8pGjUaX2LwAdea692GkvGXLwccYprqpwoD9tOsfLIDTjbUlVuCOZGu0YVTY7Y3f32NPp6f9tvXZvf-8rZ93DWGbHhpnLDCUMOkBKnBSXB2EK3hRFtGneK6I602TmrNJQfaESNa3ZJBaMWt45at0d0vtzr-XGwu_TEuqTrJ_WZDK5YCVFHzKzIp5pys6-fkJ5W-ewL9KcT-X4jsB5VjZcA</recordid><startdate>20000301</startdate><enddate>20000301</enddate><creator>Meisner, M.</creator><creator>Schmidt, J.</creator><creator>Hüttner, H.</creator><creator>Tschaikowsky, K.</creator><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20000301</creationdate><title>The natural elimination rate of procalcitonin in patients with normal and impaired renal function</title><author>Meisner, M. ; Schmidt, J. ; Hüttner, H. ; Tschaikowsky, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Creatinine</topic><topic>Dopamine</topic><topic>Gender</topic><topic>Inflammation</topic><topic>Intensive care</topic><topic>Molecular weight</topic><topic>Patients</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Renal replacement therapy</topic><topic>Sepsis</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meisner, M.</creatorcontrib><creatorcontrib>Schmidt, J.</creatorcontrib><creatorcontrib>Hüttner, H.</creatorcontrib><creatorcontrib>Tschaikowsky, K.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meisner, M.</au><au>Schmidt, J.</au><au>Hüttner, H.</au><au>Tschaikowsky, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The natural elimination rate of procalcitonin in patients with normal and impaired renal function</atitle><jtitle>Intensive care medicine</jtitle><date>2000-03-01</date><risdate>2000</risdate><volume>26</volume><issue>S2</issue><spage>S212</spage><epage>S216</epage><pages>S212-S216</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><abstract>Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half-life time of PCT after peak concentrations in patients with normal and impaired renal function. We also have analyzed the influence of patients age and gender on PCT elimination kinetic.¶Design: Prospective clinical study. Renal dysfunction was assessed by plasma creatinine. The half-life time of PCT was evaluated 24 and 48 h after acute induction of PCT, when the focus of PCT induction has rapidly been eliminated.¶Setting: Intensive care unit of our University hospital, a tertiary health care institution.¶Patients: 69 patients were included into the study.¶Interventions: None.¶Measurements and results: The half-life-time of PCT was not significantly altered during renal dysfunction (26.1-33.1 h, 25-50 percentiles, creatinine clearance &lt; 30 ml/min) when compared with normal renal function (22.3-28.9 h). It neither correlated with creatinine clearance (p = 0.14), nor age (p = 0.99) or gender (p = 0.90, Pearson product-moment correlation).¶Conclusions: The data of the present study demonstrate that assement of PCT kinetic can also be used for diagnostic and prognostic reasons in patients with renal dysfunction. It may, however, exceed 24 h also in patients with normal renal function. As to the present knowledge, renal secretion does not contribute as a main pathway to PCT elimination.[PUBLICATION ABSTRACT]</abstract><cop>Heidelberg</cop><pub>Springer Nature B.V</pub><doi>10.1007/s001340051146</doi></addata></record>
fulltext fulltext
identifier ISSN: 0342-4642
ispartof Intensive care medicine, 2000-03, Vol.26 (S2), p.S212-S216
issn 0342-4642
1432-1238
language eng
recordid cdi_proquest_journals_992880200
source Springer Nature
subjects Creatinine
Dopamine
Gender
Inflammation
Intensive care
Molecular weight
Patients
Plasma
Proteins
Renal replacement therapy
Sepsis
Urine
title The natural elimination rate of procalcitonin in patients with normal and impaired renal function
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A19%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20natural%20elimination%20rate%20of%20procalcitonin%20in%20patients%20with%20normal%20and%20impaired%20renal%20function&rft.jtitle=Intensive%20care%20medicine&rft.au=Meisner,%20M.&rft.date=2000-03-01&rft.volume=26&rft.issue=S2&rft.spage=S212&rft.epage=S216&rft.pages=S212-S216&rft.issn=0342-4642&rft.eissn=1432-1238&rft_id=info:doi/10.1007/s001340051146&rft_dat=%3Cproquest_cross%3E2629295361%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=992880200&rft_id=info:pmid/&rfr_iscdi=true